• The Hamner and C-Path Announce New Collaboration

    The Hamner partners with internationally renowned Critical Path Institute to advance science focused on drug safety. Hamner efforts will be led by Dr. Paul Watkins, IDSS Director.

    LEARN MORE

  • Dr. Russell Thomas Selected for Agilent Award

    ICSS Director receives Thought Leader Award to support his work developing methods to predict drug-induced liver injury

    LEARN MORE

  • The DILI-sim Initiative

    The Hamner-UNC Institute for Drug Safety Sciences is spearheading a multi-stakeholder partnership aimed at predicting drug-induced liver injury

    LEARN MORE

The Hamner performs cutting-edge research to improve chemical and drug safety and speed the development of new breakthrough medicines.

The Hamner Institutes for Health Sciences brings together safety assessments for chemicals and drugs, world-class education and training, and accelerated technology development on a single, multidisciplinary campus in the heart of North Carolina's Research Triangle.

With a commitment to innovation, public-private partnerships, and the creation of a global biosciences gateway, The Hamner strives to be "the translational research model for the 21st century."

SUBSCRIBE TO OUR NEWSLETTER

AT THE HAMNER NEWSLETTER

Please click the link below to view our most recent issue and learn all the latest on Hamner research programs and initiatives.

Learn More